FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 14, 2017

Study Completion Date

December 14, 2017

Conditions
Advanced Gastric Cancer
Interventions
DRUG

Pazopanib

Adding Pazopanib to a standard chemotherapy consisting of FLO. 800 mg (2x400mg or 4x200mg) Pazopanib per day should be taken orally without food at least one hour before or two hours after a meal. Pazopanib will be given d1-14 each cycle (2 weeks cycles) with 12 cycles of chemotherapy FLO (d 1, each cycle). After 12 cycles chemotherapy FLO will be discontinued and Pazopanib will be given alone until disease progression

DRUG

5-FU, Oxaliplatin, Leukovorin (FLO)

Oxaliplatin 85 mg/m2 2h iv Leucovorin 200mg/m2 2h - iv FU 2600mg/m2 24h iv q2w for 12 cycles

Trial Locations (1)

13353

Charite University medicine, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT01503372 - FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter